Global Anti-Venom Market Growth, Report & Trends Analysis 2023-2028

IMARC Group, a leading market research company, has recently releases report titled "Anti-Venom Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028." The study provides a detailed analysis of the industry, including the global anti-venom market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How Big is the Anti-Venom Market?

The global anti-venom market size reached US$ 1,096.1 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,644.9 Million by 2028, exhibiting a growth rate (CAGR) of 6.7% during 2023-2028.

Get Your Free Sample Copy of This Report: https://www.imarcgroup.com/anti-venom-market/requestsample

Anti-venom, also known as antivenin, is a medication or treatment used to counteract the effects of venomous bites or stings from venomous animals, such as snakes, spiders, scorpions, or certain marine creatures. It is a specific type of antitoxin designed to neutralize the toxic components present in venom. It neutralizes the toxins and counteracts the effects of the venom, which prevents them from causing life-threatening complications such as respiratory failure or organ damage. It aids in treating venomous bites and stings, which depend on their history, examination, and geographic, clinical, and pathologic factors.

Inquiry Before Buying: https://www.imarcgroup.com/request?type=report&id=5147&flag=F

What are the growth prospects and trends in the anti-venom industry?

The increasing number of areas that are more prone to venomous snakes represents one of the primary factors driving the demand for anti-venom around the world. Moreover, the rising cases of venomous bites and stings in rural and tropical regions are favoring the growth of the market.

In addition, the growing consumer awareness of the importance of snake bite prevention and the easy availability of anti-venom at an affordable price is influencing the market positively.

Apart from this, the advent of various rapid snake venom detection kits, which uses a rapid enzyme immunoassay to analyze and identify snake venom via samples taken from bite sites, urine, plasma, or blood, is strengthening the growth of the market.

The report has segmented the market on the basis of region, species, anti-venom type, mode of action and end user.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/anti-venom-market

Breakup by Species:
• Snake
• Scorpion
• Spider
• Others

Breakup by Anti-venom Type:
• Polyvalent Anti-venom
• Monovalent Anti-venom

Breakup by Mode of Action:
• Cytotoxic
• Neurotoxic
• Haemotoxic
• Cardiotoxic
• Myotoxic
• Others

Breakup by End User:
• Hospitals
• Clinics
• Ambulatory Surgical Centers

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

Bharat Serums and Vaccines Limited (BSV)
Boehringer Ingelheim International GmbH
Boston Scientific Corporation
CSL Limited
Haffkine Bio-Pharmaceutical Corporation Limited Incepta Pharmaceuticals Limited
Merck & Co. Inc.
Merck KGaA
MicroPharm Limited
Pfizer Inc.
Rare Disease Therapeutics Inc.

IMARC Services Private Limited.
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.